A near 30% increase in Daybue sales above projections, coupled with a lower than expected dropout rate, suggests that the revenue side is undervalued by at least that number, and if half the value of Neuren is made up from the income stream from Daybue, then new analyses should increase the valuation from c$20 to at least $23. Still trading at 50% of its value means it's a buy even with the recent increases.
A near 30% increase in Daybue sales above projections, coupled...
-
- There are more pages in this discussion • 3,044 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.16 |
Change
0.160(0.80%) |
Mkt cap ! $2.572B | |||
| Open | High | Low | Value | Volume |
| $20.05 | $20.28 | $19.83 | $2.181M | 108.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 64 | $20.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.18 | 84 | 7 |
View Market Depth
| Last trade - 12.25pm 24/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |